Investor Relations
Krones provides its shareholders with up-to-date and transparent information. On the following pages you will find extensive information on investment in the market leader in filling and packaging technology.
-
Krones expands its capabilities in the growing pharmaceutical market
-
Quarterly statement Q3 2022
-
Conference Call Krones Group third quarter 2022
-
Krones raises guidance for revenue growth in 2022
-
Krones commits to Net Zero
Keep scrolling
Why invest in Krones?
Krones is the market and technology leader
Krones operates in markets with stable growth
Krones is increasing its profitability
Krones has a strong services business
Krones has a strong position internationally
Krones creates sustainable value
Facts and figures at a glance
Krones raised guidance in October for revenue growth in 2022
Due to the continued very strong demand for Krones products and services, as well as good management of scarce resources, the company expects to maintain good production capacity utilisation in the fourth quarter of 2022.
On 19 October, on the basis of current planning, Krones therefore raised its guidance for revenue growth in the full year 2022 from previously between 5% and 8% to between 10% and 12%. The guidance for the other two financial targets remains unchanged.
| Guidance for 2022 | Actual 9m 2022 | |
| Revenue growth | 10–12% (previously 5–8%) |
15.2% |
| EBITDA margin | 8–9% | 8.9% |
| ROCE | 10–12% | 12.4% |
